Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

The European antibody network's practical guide to finding and validating suitable antibodies for research. (CROSBI ID 222497)

Prilog u časopisu | pregledni rad (znanstveni) | međunarodna recenzija

Roncador G ; Engel P ; Maestre L, Anderson AP ; Cordell JL ; Cragg MS ; Šerbec VČ ; Jones M, Juranić Lisnić, Vanda ; Kremer, L ; Li D ; Koch-Nolte F et al. The European antibody network's practical guide to finding and validating suitable antibodies for research. // mAbs, e-pub ahead of p (2015), e-pub ahead of p; doi: 10.1080/19420862.2015.1100787

Podaci o odgovornosti

Roncador G ; Engel P ; Maestre L, Anderson AP ; Cordell JL ; Cragg MS ; Šerbec VČ ; Jones M, Juranić Lisnić, Vanda ; Kremer, L ; Li D ; Koch-Nolte F ; Pascual N ; Rodríguez-Barbosa JI ; Torensma R ; Turley H ; Pulford K ; Banham AH.

engleski

The European antibody network's practical guide to finding and validating suitable antibodies for research.

Antibodies are widely exploited as research/diagnostic tools and therapeutics. Despite providing exciting research opportunities, the multitude of available antibodies also offers a bewildering array of choice. Importantly, not all companies comply with the highest standards, and thus many reagents fail basic validation tests. The responsibility for antibodies being fit for purpose rests, surprisingly, with their user. This paper condenses the extensive experience of the European Monoclonal Antibody Network to help researchers identify antibodies specific for their target antigen. A stepwise strategy is provided for prioritising antibodies and making informed decisions regarding further essential validation requirements. Web-based antibody validation guides provide practical approaches for testing antibody activity and specificity. We aim to enable researchers with little or no prior experience of antibody characterization to understand how to determine the suitability of their antibody for its intended purpose, enabling both time and cost effective generation of high quality antibody- based data fit for publication.

BLAST searches ; CiteAb ; EuroMAbNet ; flow cytometry ; gene silencing ; HLDA workshops ; immunohistochemistry ; monoclonal antibodies ; validation studies ; western blotting

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

e-pub ahead of p (e-pub ahead of p)

2015.

objavljeno

1942-0862

10.1080/19420862.2015.1100787

Povezanost rada

Temeljne medicinske znanosti

Poveznice
Indeksiranost